Huntingtin fragments and SOD1 mutants form soluble oligomers in the cell

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Park, Yang Nim ^a   Zhao, Xiaohong ^a   Norton, Mark ^a   Taylor, J Paul ^b   Eisenberg, Evan ^a   Greene, Lois E ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHAPERONE; COPPER ZINC SUPEROXIDE DISMUTASE; HEAT SHOCK PROTEIN 40; HEAT SHOCK PROTEIN 70; HUNTINGTIN; OLIGOMER;

ARTICLE; CELL DEATH; CELL MOTILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DEPOLYMERIZATION; EXON; HUMAN; HUMAN CELL; OLIGOMERIZATION; POINT MUTATION; PROTEIN EXPRESSION; PROTEIN FUNCTION;

ANIMALS; BLOTTING, WESTERN; CELL EXTRACTS; DIFFUSION; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; MICE; MUTANT PROTEINS; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; PEPTIDES; POINT MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEASOME INHIBITORS; PROTEIN STRUCTURE, QUATERNARY; SOLUBILITY; SUPEROXIDE DISMUTASE; TIME FACTORS; TRANSFECTION;

EID: 84863100334     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040329     Document Type: Article

References (60)

1. Ross CA, Poirier MA, (2004) Protein aggregation and neurodegenerative disease. Nat Med 10.
2. Tarlac V, Storey E, (2003) Role of proteolysis in polyglutamine disorders. J Neurosci Research 74: 406-416.
3. Orr HT, Zoghbi HY, (2007) Trinucleotide Repeat Disorders. Ann Rev Neurosci 30: 575-621.
4. Cooper JK, Schilling G, Peters MF, Herring WJ, Sharp AH, et al. (1998) Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum Mol Genet 7: 783-790.
5. Martindale D, Hackam A, Wieczorek A, Ellerby L, Wellington C, et al. (1998) Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat Genet 18: 150-154.
6. Hackam AS, Singaraja R, Zhang T, Gan L, Hayden MR, (1999) In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease. Hum Mol Genet 8: 25-33.
7. Arrasate M, Mitra S, Schweitzer ES, Segal MR, Finkbeiner S, (2004) Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431: 805-810.
8. Takahashi T, Kikuchi S, Katada S, Nagai Y, Nishizawa M, et al. (2008) Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic. Hum Mol Genet 17: 345-356.
9. Miller J, Arrasate M, Shaby BA, Mitra S, Masliah E, et al. (2010) Quantitative Relationships between Huntingtin Levels, Polyglutamine Length, Inclusion Body Formation, and Neuronal Death Provide Novel Insight into Huntington's Disease Molecular Pathogenesis. J Neurosci 30: 10541-10550.
10. Nagai Y, Inui T, Popiel HA, Fujikake N, Hasegawa K, et al. (2007) A toxic monomeric conformer of the polyglutamine protein. Nat Struct Mol Biol 14: 332-345.
11. Takahashi Y, Okamoto Y, Popiel HA, Fujikake N, Toda T, et al. (2007) Detection of Polyglutamine Protein Oligomers in Cells by Fluorescence Correlation Spectroscopy. J Biol Chem 282: 24039-24048.
12. Mukai H, Isagawa T, Goyama E, Tanaka S, Bence NF, et al. (2005) Formation of morphologically similar globular aggregates from diverse aggregation-prone proteins in mammalian cells. Proc Natl Acad Sci USA 102: 10887-10892.
13. Olshina MA, Angley LM, Ramdzan YM, Tang J, Bailey MF, et al. (2010) Tracking Mutant Huntingtin Aggregation Kinetics in Cells Reveals Three Major Populations That Include an Invariant Oligomer Pool. J Biol Chem 285: 21807-21816.
14. Sathasivam K, Lane A, Legleiter J, Warley A, Woodman B, et al. (2010) Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease. Hum Mol Genet 19: 65-78.
15. Shaw BF, Valentine JS, (2007) How do ALS-associated mutations in superoxide dismutase 1 promote aggregation of the protein? Trends Biochem Sci 32: 78-85.
16. Valentine JS, Hart PJ, (2003) Misfolded CuZnSOD and amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 100: 3617-3622.
17. Karch CM, Prudencio M, Winkler DD, Hart PJ, Borchelt DR, (2009) Role of mutant SOD1 disulfide oxidation and aggregation in the pathogenesis of familial ALS. Proc Natl Acad Sci USA 106: 7774-7779.
18. Vogel SS, Thaler C, Koushik SV, (2006) Fanciful FRET. Sci STKE 2006: re2-.
19. Matsumoto G, Kim S, Morimoto RI, (2006) Huntingtin and mutant SOD1 form aggregate structures with distinct molecular properties in human cells. J Biol Chem 281: 4477-4485.
20. Banci L, Bertini I, Boca M, Girotto S, Martinelli M, et al. (2008) SOD1 and Amyotrophic Lateral Sclerosis: Mutations and Oligomerization. PLoS ONE 3: e1677.
21. Banci L, Bertini I, Durazo A, Girotto S, Gralla EB, et al. (2007) Metal-free superoxide dismutase forms soluble oligomers under physiological conditions: A possible general mechanism for familial ALS. Proc Natl Acad Sci USA 104: 11263-11267.
22. Banci L, Bertini I, Boca M, Calderone V, Cantini F, et al. (2009) Structural and dynamic aspects related to oligomerization of apo SOD1 and its mutants. Proc Natl Acad Sci USA 106: 6980-6985.
23. Crick SL, Jayaraman M, Frieden C, Wetzel R, Pappu RV, (2006) Fluorescence correlation spectroscopy shows that monomeric polyglutamine molecules form collapsed structures in aqueous solutions. Proc Natl Acad Sci USA 103: 16764-16769.
24. Kazantsev A, Preisinger E, Dranovsky A, Goldgaber D, Housman D, (1999) Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc Natl Acad Sci USA 96: 11404-11409.
25. Krishnan U, Son M, Rajendran B, Elliott JL, (2006) Novel mutations that enhance or repress the aggregation potential of SOD1. Mol Cell Biochem 287: 201-211.
26. Salazar-Grueso EF, Kim S, Kim H, (1991) Embryonic mouse spinal cord motor neuron hybrid cells. Neuroreport 2: 505-508.
27. Blusztajn JK, Venturini A, Jackson DA, Lee HJ, Wainer BH, (1992) Acetylcholine synthesis and release is enhanced by dibutyryl cyclic AMP in a neuronal cell line derived from mouse septum. J Neurosci 12: 793-799.
28. Weisshart K, Jungel V, Briddon SJ, (2004) The LSM 510 META - ConfoCor 2 system: an integrated imaging and spectroscopic platform for single-molecule detection. Curr Pharm Biotechnol 5: 135-154.
29. Bacia K, Kim SA, Schwille P, (2006) Fluorescence cross-correlation spectroscopy in living cells. Nat Meth 3: 83-89.
30. Schwille P, Haupts U, Maiti S, Webb WW, (1999) Molecular Dynamics in Living Cells Observed by Fluorescence Correlation Spectroscopy with One- and Two-Photon Excitation. Biophysical Journal 77: 2251-2265.
31. Johnston JA, Ward CL, Kopito RR, (1998) Aggresomes: A Cellular Response to Misfolded Proteins. J Cell Biol 143: 1883-1898.
32. Brock R, Vamosi G, Vereb G, Jovin TM, (1999) Rapid characterization of green fluorescent protein fusion proteins on the molecular and cellular level by fluorescence correlation microscopy. Proc Natl Acad Sci USA 96: 10123-10128.
33. Elsner M, Hashimoto H, Simpson JC, Cassel D, Nilsson T, et al. (2003) Spatiotemporal dynamics of the COPI vesicle machinery. EMBO Rep 4: 1000-1004.
34. Muchowski PJ, Schaffar G, Sittler A, Wanker EE, Hayer-Hartl MK, et al. (2000) Hsp70 and Hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils. Proc Natl Acad Sci USA 97: 7841-7846.
35. Chai Y, Koppenhafer SL, Bonini NM, Paulson HL, (1999) Analysis of the Role of Heat Shock Protein (Hsp) Molecular Chaperones in Polyglutamine Disease. J Neurosci 19: 10338-10347.
36. Cummings CJ, Mancini MA, Antalffy B, DeFranco DB, Orr HT, et al. (1998) Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet 19: 148-154.
37. Waelter S, Boeddrich A, Lurz R, Scherzinger E, Lueder G, et al. (2001) Accumulation of Mutant Huntingtin Fragments in Aggresome-like Inclusion Bodies as a Result of Insufficient Protein Degradation. Molecular Biology of the Cell 12: 1393-1407.
38. Kim S, Nollen EAA, Kitagawa K, Bindokas VP, Morimoto RI, (2002) Polyglutamine protein aggregates are dynamic. Nat Cell Biol 4: 826.
39. Yu ZX, Li SH, Evans J, Pillarisetti A, Li H, et al. (2003) Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease. J Neurosci 23: 2193-2202.
40. Thakur AK, Jayaraman M, Mishra R, Thakur M, Chellgren VM, et al. (2009) Polyglutamine disruption of the huntingtin exon 1 N terminus triggers a complex aggregation mechanism. Nat Struct Mol Biol 16: 380-389.
41. Bhattacharyya A, Thakur AK, Chellgren VM, Thiagarajan G, Williams AD, et al. (2006) Oligoproline Effects on Polyglutamine Conformation and Aggregation. J Mol Biol 355: 524-535.
42. Johnston JA, Dalton MJ, Gurney ME, Kopito RR, (2000) Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 97: 12571-12576.
43. Zhang F, Zhu H, (2006) Intracellular conformational alterations of mutant SOD1 and the implications for fALS-associated SOD1 mutant induced motor neuron cell death. Biochim Biophys, Acta 1760: 404-414.
44. Legleiter J, Mitchell E, Lotz GP, Sapp E, Ng C, et al. (2010) Mutant Huntingtin Fragments Form Oligomers in a Polyglutamine Length-dependent Manner in Vitro and in Vivo. J Biol Chem 285: 14777-14790.
45. Lotz GP, Legleiter J, Aron R, Mitchell EJ, Huang S-Y, et al. (2010) Hsp70 and Hsp40 Functionally Interact with Soluble Mutant Huntingtin Oligomers in a Classic ATP-dependent Reaction Cycle. J Biol Chem 285: 38183-38193.
46. Lajoie P, Snapp EL, (2010) Formation and Toxicity of Soluble Polyglutamine Oligomers in Living Cells. PLoS ONE 5: e15245.
47. Ossato G, Digman MA, Aiken C, Lukacsovich T, Marsh JL, et al. (2010) A Two-Step Path to Inclusion Formation of Huntingtin Peptides Revealed by Number and Brightness Analysis. Biophys J 98: 3078-3085.
48. Wacker JL, Zareie MH, Fong H, Sarikaya M, Muchowski PJ, (2004) Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer. Nat Struct Mol Biol 11: 1215-1222.
49. Ren P, Lauckner JE, Kachirskaia I, Heuser JE, Melki R, et al. (2009) Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates. Nat Cell Biol 11: 219-225.
50. Borchelt DR, Lee MK, Slunt HS, Guarnieri M, Xu ZS, et al. (1994) Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 91: 8292-8296.
51. Okado-Matsumoto A, Fridovich I, (2002) Amyotrophic lateral sclerosis: A proposed mechanism. Proc Natl Acad Sci USA 99: 9010-9014.
52. Bruening W, Roy J, Giasson B, Figlewicz DA, Mushynski WE, et al. (1999) Up-Regulation of Protein Chaperones Preserves Viability of Cells Expressing Toxic Cu/Zn-Superoxide Dismutase Mutants Associated with Amyotrophic Lateral Sclerosis. J Neurochem 72: 693-699.
53. Takeuchi H, Kobayashi Y, Yoshihara T, Niwa J, Doyu M, et al. (2002) Hsp70 and Hsp40 improve neurite outgrowth and suppress intracytoplasmic aggregate formation in cultured neuronal cells expressing mutant SOD1. Brain Research 949: 11-22.
54. Liu J, Shinobu LA, Ward CM, Young D, Cleveland DW, (2005) Elevation of the Hsp70 chaperone does not effect toxicity in mouse models of familial amyotrophic lateral sclerosis. J Neurochem 93: 875-882.
55. Wang J, Farr GW, Zeiss CJ, Rodriguez-Gil DJ, Wilson JH, et al. (2009) Progressive aggregation despite chaperone associations of a mutant SOD1-YFP in transgenic mice that develop ALS. Proc Natl Acad Sci USA 106: 1392-1397.
56. Juneja T, Pericak-Vance MA, Laing NG, Dave S, Siddique T, (1997) Prognosis in familial amyotrophic lateral sclerosis: progression and survival in patients with glu100gly and ala4val mutations in Cu, Zn superoxide dismutase. Neurology 48: 55-57.
57. Wang Q, Johnson JL, Agar NYR, Agar JN, (2008) Protein Aggregation and Protein Instability Govern Familial Amyotrophic Lateral Sclerosis Patient Survival. PLoS Biol 6: e170.
58. Prudencio M, Hart PJ, Borchelt DR, Andersen PM, (2009) Variation in aggregation propensities among ALS-associated variants of SOD1: correlation to human disease. Hum Mol Genet 18: 3217-3226.
59. Wang L, Deng H-X, Grisotti G, Zhai H, Siddique T, et al. (2009) Wild-type SOD1 overexpression accelerates disease onset of a G85R SOD1 mouse. Hum Mol Genet 18: 1642-1651.
60. Prudencio M, Durazo A, Whitelegge JP, Borchelt DR, (2010) An examination of wild-type SOD1 in modulating the toxicity and aggregation of ALS-associated mutant SOD1. Hum Mol Genet 19: 4774-4789.